Tabatha Adams
Family · Bonneau, SCNPI 1528292794
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 156 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 12.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,686 and has fallen 96.1% since, to $67 in 2023.
Across 156 payments — averaging $16.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$323
- Novo Nordisk$266
- Lilly USA, LLC$259
- Takeda Pharmaceuticals U.S.A., Inc.$178
- Johnson & Johnson$173
- AstraZeneca$167
- plus $1K from 25 others
What the payments were for
- Food & beverage$2,607100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 18 | $323 |
| Novo Nordisk | 21 | $266 |
| Lilly USA, LLC | 15 | $259 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $178 |
| Johnson & Johnson | 13 | $173 |
| AstraZeneca | 11 | $167 |
| Novartis | 7 | $132 |
| Amarin Pharma, Inc. | 5 | $115 |
| Pfizer | 6 | $105 |
| Bayer | 6 | $97 |
| AbbVie | 6 | $95 |
| Merck | 5 | $91 |
| GSK | 5 | $87 |
| Abbott | 3 | $70 |
| Eisai Inc. | 4 | $56 |
| Vanda Pharmaceuticals Inc. | 2 | $52 |
| E.r. Squibb & Sons, L.L.C. | 2 | $44 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $37 |
| Ironwood Pharmaceuticals, Inc | 2 | $36 |
| Mylan Specialty L.p. | 2 | $33 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Biohaven Pharmaceuticals, Inc. | 1 | $23 |
| Sunovion Pharmaceuticals Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Eyevance Pharmaceuticals LLC | 1 | $15 |
| Hikma Pharmaceuticals USA | 1 | $15 |
| Dexcom, Inc. | 1 | $14 |
| Esperion Therapeutics, Inc. | 1 | $13 |
| Currax Pharmaceuticals LLC | 1 | $12 |
How this compares
$2,607 in reported general payments places this provider in the 80th percentile of 3,248 family providers in South Carolina.
Other family in Bonneau
- Sara ChristieGreenville$229K
- Kara Cooper GilmerAnderson$127K
- Jessica BellEasley$96K
- Carrie HendersonGreenville$91K
- Sarah ValerioGreer$76K
- Mary WilliamsColumbia$67K
- Michelle StrongGreenville$55K
- Karen McKerihanSummerville$54K
- Doris ReidSimpsonville$25K
- Hailey AtkinsonIrmo$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.